Two Suspected Ebola Cases In Adamawa Test Negative – NCDC Source

Markus Habila
Editor

Two Suspected Ebola Cases In Adamawa Test Negative – NCDC Source
The two suspected cases of Ebola Virus Disease reported in Nigeria’s North-East have tested negative following laboratory investigations, a reliable source at the Nigeria Centre for Disease Control and Prevention (NCDC) has disclosed.
The source, who confirmed the development in Abuja on Saturday, said the suspected cases were recorded in Adamawa State and that laboratory analysis of samples collected from the individuals returned negative results.
The clarification comes hours after the NCDC announced the identification of two suspected Ebola cases in the North-East, prompting concerns over a possible spread of the disease beyond the Federal Capital Territory.
In its Saturday update, the agency said both individuals had been isolated while contact identification, listing and laboratory investigations were ongoing.
However, the NCDC did not initially disclose the states where the suspected cases were identified or provide details about the individuals.
The agency also cautioned that being classified as suspected cases did not mean the individuals had contracted Ebola, noting that laboratory results would determine their status.
The latest development, according to the Abuja-based source, indicates that the two suspected cases in Adamawa have been ruled out following laboratory analysis.
Nigeria is currently responding to an imported case of Ebola caused by the Bundibugyo virus strain, confirmed on October 20, 2026, involving a 42-year-old woman who travelled from Uganda to Abuja.
The patient was subsequently evacuated to Switzerland on October 26 for continued medical care.
The confirmation of the imported case triggered intensified surveillance, contact tracing and emergency response measures by health authorities.
The NCDC has urged Nigerians to maintain proper hand hygiene, practise enhanced sanitation and comply with public health advisories while investigations and surveillance continue.